Unified Huntington's disease rating scale: Reliability and consistency

Movement Disorders

Volumn 11, Issue 2, 1996, Pages 136-142

  Kieburtz, K ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Behavioural abnormalities; Clinical research; Cognitive function; Functional capacity; Huntington's disease

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIOR; CLINICAL FEATURE; COGNITION; DATA BASE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; SCHOOL CHILD; TIME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; MOTOR DYSFUNCTION; MULTICENTER STUDY; NAUSEA; NEUROPROTECTION; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

AMANTADINE; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMATE RECEPTOR ANTAGONIST; LEVODOPA; METHYLDOPA; METOCLOPRAMIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; REMACEMIDE; SELEGILINE; TRICYCLIC ANTIDEPRESSANT AGENT;

EID: 85009332113     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110204     Document Type: Article

References (12)

1. Folstein SE, Jensen B, Leigh JR, Holstein MF. The measurement of abnormal movement: methods developed for Huntington's disease. Neurobehav Toxicol Teratol 1983;5: 605-609.
2. Shoulson I, Fahn S. Huntington's disease: clinical care and evaluation. Neurology 1979;29:1-3.
3. Young AB, Shoulson I, Penney JB, et al. Huntington's disease in Venezuela: neurologic features and functional decline. Neurology 1986;36:244.
4. Myers RH, Sax DS, Koroshetz WF, et al. Factors associated with slow progression in Huntington's disease. Arch Neurol 1991;48:800-804.
5. Marsden CD, Schachter M. Assessment of extrapyramidal disorders. Br J Clin Pharmacol 1981;11:129-151.
6. Bylsma FW, Rothlind J, Hall MR, Folstein SE, Brandt J. Assessment of adaptive functioning in Huntington's disease. Mov Disord 1993;8:183-190.
7. Roos RAC, Hermans J, Vegtyer-van der VM, van Ommen GJB, Bruyn GW. Duration of illness in Huntington's disease is not related to age at onset. J Neurol Neurosurg Psychiatry 1993;56:98-100.
8. Benton AL, Hamsher K deS. Multilingual aphasia examination manual. Iowa City: University of Iowa, 1978.
9. Smith A. Symbol digit modalities test manual, Los Angeles: Western Psychological Services, 1973.
10. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-662.
11. Shoulson I, Kurlan R, Rubin AJ, et al. Assessment of functional capacity in neurodegenerative movement disorders: Huntington's disease as a prototype. In: Munsat TL, ed. Quantification of neurologica deficit. Boston: Butterworths, 1989:271-283.
12. Young AB, Penney JB, Starosta-Rubinstein S, et al. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol 1986;20:296-303.